INTUITIVE SURGICAL INC (IUI1.DE) Stock Fundamental Analysis
Europe - Frankfurt Stock Exchange - FRA:IUI1 - US46120E6023 - Common Stock
438.55 EUR
-0.55 (-0.13%)
Overall IUI1 gets a fundamental rating of 5 out of 10. We evaluated IUI1 against 63 industry peers in the Health Care Equipment & Supplies industry. Both the health and profitability get an excellent rating, making IUI1 a very profitable company, without any liquidiy or solvency issues. IUI1 is valied quite expensively at the moment, while it does show a decent growth rate. These ratings would make IUI1 suitable for quality investing!
1. Profitability
1.1 Basic Checks
- IUI1 had positive earnings in the past year.
- In the past year IUI1 had a positive cash flow from operations.
- Of the past 5 years IUI1 4 years were profitable.
- Of the past 5 years IUI1 4 years had a positive operating cash flow.
1.2 Ratios
- IUI1's Return On Assets of 14.19% is amongst the best of the industry. IUI1 outperforms 92.06% of its industry peers.
- With an excellent Return On Equity value of 16.12%, IUI1 belongs to the best of the industry, outperforming 84.13% of the companies in the same industry.
- IUI1 has a better Return On Invested Capital (11.69%) than 84.13% of its industry peers.
- IUI1 had an Average Return On Invested Capital over the past 3 years of 9.53%. This is in line with the industry average of 9.95%.
- The last Return On Invested Capital (11.69%) for IUI1 is above the 3 year average (9.53%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 14.19% | ||
| ROE | 16.12% | ||
| ROIC | 11.69% |
ROA(3y)11.41%
ROA(5y)11.26%
ROE(3y)13.21%
ROE(5y)12.97%
ROIC(3y)9.53%
ROIC(5y)9.27%
1.3 Margins
- IUI1 has a Profit Margin of 28.58%. This is amongst the best in the industry. IUI1 outperforms 98.41% of its industry peers.
- IUI1's Profit Margin has declined in the last couple of years.
- With an excellent Operating Margin value of 29.44%, IUI1 belongs to the best of the industry, outperforming 96.83% of the companies in the same industry.
- In the last couple of years the Operating Margin of IUI1 has declined.
- The Gross Margin of IUI1 (66.38%) is better than 73.02% of its industry peers.
- In the last couple of years the Gross Margin of IUI1 has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 29.44% | ||
| PM (TTM) | 28.58% | ||
| GM | 66.38% |
OM growth 3Y-4.19%
OM growth 5Y-1.68%
PM growth 3Y-2.34%
PM growth 5Y-2.02%
GM growth 3Y-0.91%
GM growth 5Y-0.58%
2. Health
2.1 Basic Checks
- The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so IUI1 is still creating some value.
- IUI1 has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
- IUI1 has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | N/A |
ROIC/WACC1.16
WACC10.06%
2.3 Liquidity
- A Current Ratio of 4.97 indicates that IUI1 has no problem at all paying its short term obligations.
- IUI1's Current ratio of 4.97 is amongst the best of the industry. IUI1 outperforms 96.83% of its industry peers.
- IUI1 has a Quick Ratio of 4.20. This indicates that IUI1 is financially healthy and has no problem in meeting its short term obligations.
- Looking at the Quick ratio, with a value of 4.20, IUI1 belongs to the top of the industry, outperforming 96.83% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 4.97 | ||
| Quick Ratio | 4.2 |
3. Growth
3.1 Past
- IUI1 shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 21.83%, which is quite impressive.
- IUI1 shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 21.42% yearly.
EPS 1Y (TTM)21.83%
EPS 3Y23.94%
EPS 5Y21.42%
EPS Q2Q%14.48%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%18.76%
3.2 Future
- The Earnings Per Share is expected to grow by 15.07% on average over the next years. This is quite good.
- IUI1 is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 12.31% yearly.
EPS Next Y11.25%
EPS Next 2Y13.22%
EPS Next 3Y13.64%
EPS Next 5Y15.07%
Revenue Next Year15.2%
Revenue Next 2Y14.36%
Revenue Next 3Y13.92%
Revenue Next 5Y12.31%
3.3 Evolution
- Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. Valuation
4.1 Price/Earnings Ratio
- Based on the Price/Earnings ratio of 58.79, the valuation of IUI1 can be described as expensive.
- Compared to the rest of the industry, the Price/Earnings ratio of IUI1 is on the same level as its industry peers.
- When comparing the Price/Earnings ratio of IUI1 to the average of the S&P500 Index (28.60), we can say IUI1 is valued expensively.
- With a Price/Forward Earnings ratio of 52.86, IUI1 can be considered very expensive at the moment.
- Compared to the rest of the industry, the Price/Forward Earnings ratio of IUI1 indicates a slightly more expensive valuation: IUI1 is more expensive than 69.84% of the companies listed in the same industry.
- IUI1's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 25.83.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 58.79 | ||
| Fwd PE | 52.86 |
4.2 Price Multiples
- Based on the Enterprise Value to EBITDA ratio, IUI1 is valued a bit more expensive than 66.67% of the companies in the same industry.
- IUI1's Price/Free Cash Flow ratio is in line with the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 81.96 | ||
| EV/EBITDA | 51.53 |
4.3 Compensation for Growth
- The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates IUI1 does not grow enough to justify the current Price/Earnings ratio.
- The decent profitability rating of IUI1 may justify a higher PE ratio.
- IUI1's earnings are expected to grow with 13.64% in the coming years. This may justify a more expensive valuation.
PEG (NY)5.23
PEG (5Y)2.74
EPS Next 2Y13.22%
EPS Next 3Y13.64%
5. Dividend
5.1 Amount
- IUI1 does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
INTUITIVE SURGICAL INC / IUI1.DE FAQ
Can you provide the ChartMill fundamental rating for INTUITIVE SURGICAL INC?
ChartMill assigns a fundamental rating of 5 / 10 to IUI1.DE.
Can you provide the valuation status for INTUITIVE SURGICAL INC?
ChartMill assigns a valuation rating of 2 / 10 to INTUITIVE SURGICAL INC (IUI1.DE). This can be considered as Overvalued.
Can you provide the profitability details for INTUITIVE SURGICAL INC?
INTUITIVE SURGICAL INC (IUI1.DE) has a profitability rating of 7 / 10.
Can you provide the financial health for IUI1 stock?
The financial health rating of INTUITIVE SURGICAL INC (IUI1.DE) is 7 / 10.